CytoMed Therapeutics
GDTC
#9848
Rank
โ‚น2.35 B
Marketcap
โ‚น203.98
Share price
1.91%
Change (1 day)
15.95%
Change (1 year)

EPS for CytoMed Therapeutics (GDTC)

EPS in 2021: -โ‚น11.82

According to CytoMed Therapeutics's latest financial reports the company's current EPS (TTM) is -โ‚น11.82. In 2021 the company made an earnings per share (EPS) of -โ‚น11.82 a decrease over its 2020 EPS that were of -โ‚น11.39.

EPS history for CytoMed Therapeutics from 2020 to 2021

Annual EPS

Year EPS Change
2021-โ‚น11.823.73%
2020-โ‚น11.39